Statins, widely studied and potentially the most promising therapy for PH, function as inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA-R), commonly used to treat hyperlipidemia [230]. Here, HMGCR is linked to hyperlipidemia.